I'm hoping that it is purely by chance, however, the participant dropout rate for the PARA _OA_008 is a little concerning, especially as we are not privy to the reasons for it occurring.
* 2 placebo doses per week - 22 enrolled and 0 dropped out
* 1 iPPS and 1 placebo per week - 20 enrolled and 3 dropped out
* 2 iPPS doses per week - 19 enrolled and 4 dropped out.
I'd love to know why the dropout rate was highest for the recipients that received the greatest amount of iPPS in the trial and lowest for the placebo recipients. It was a double-blind study however due to being a fairly small recipient number (n) one should not draw too many negative conclusions, but something irks me about it.
- Forums
- ASX - By Stock
- PAR
- Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-376
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 21.5¢ | $78.13K | 350.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 43479 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 0.220 |
12 | 212910 | 0.215 |
14 | 245866 | 0.210 |
8 | 182478 | 0.205 |
30 | 784855 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 43479 | 1 |
0.230 | 84999 | 2 |
0.235 | 26540 | 1 |
0.240 | 103500 | 4 |
0.250 | 109857 | 5 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online